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Extended longevity is often correlatedwith increased
resistance against various stressors. Insulin/IGF-1-
like signaling (IIS) is known to have a conserved
role in aging and cellular mechanisms against stress.
In C. elegans, genetic studies suggest that heat-
shock transcription factor HSF-1 is required for IIS
to modulate longevity. Here, we report that the
activity of HSF-1 is regulated by IIS. This regulation
occurs at an early step of HSF-1 activation via two
HSF-1 regulators, DDL-1 and DDL-2. Inhibition of
DDL-1/2 increases longevity and thermotolerance
in an hsf-1-dependent manner. Furthermore, bio-
chemical analyses suggest that DDL-1/2 negatively
regulate HSF-1 activity by forming a protein complex
with HSF-1. The formation of this complex (DHIC) is
affected by the phosphorylation status of DDL-1.
Both the formation of DHIC and the phosphorylation
of DDL-1 are controlled by IIS. Our findings point to
DDL-1/2 as a link between IIS and the HSF-1
pathway.
INTRODUCTION
Studies in a variety of organisms have revealed that extended
longevity is often correlated with increased resistance against
the deleterious effects of environmental and physiological
stresses, including heat-shock and oxidizing conditions (Lithgow
and Walker, 2002). In the nematode C. elegans, alterations in
a number of independent pathways, including the insulin/IGF-
1-like signaling (IIS) pathway, are known to increase longevity
and stress resistance (Kenyon, 2010). For example, loss-of-func-
tion mutations affecting the insulin/IGF-1-like receptor DAF-2
have been shown to increase longevity and resistance to heat
stress (Kenyon et al., 1993; Lithgow et al., 1995).
The IIS pathway also regulates other physiological processes
independent of longevity in worms, such as fat production,
reproduction, and dauer formation (Kimura et al., 1997). The322 Cell 148, 322–334, January 20, 2012 ª2012 Elsevier Inc.FOXO transcription factor DAF-16, which is negatively regulated
by the IIS pathway, is required for most known phenotypes that
are associated with reduced IIS (Kenyon, 2010). DAF-16 controls
the expression of a diverse set of downstream antioxidant, meta-
bolic, chaperone, antimicrobial, and other genes that act in
a cumulative way to influence longevity and stress response
(Murphy et al., 2003). Though many genes controlled by the IIS
pathway require DAF-16 for their expression, several coregula-
tors of DAF-16, such as HSF-1, SMK-1, and HCF-1, have
recently been found to function collaboratively with DAF-16 to
regulate different subsets of target genes independently in
response to different environmental stressors (Hsu et al., 2003;
Li et al., 2008; Wolff et al., 2006). It appears that, among these
coregulators of DAF-16, only HSF-1 is required for IIS to upregu-
late the transcription of genes involved in the heat-shock
response.
The heat-shock response is a fundamental and critical cellular
defensive mechanism against heat stress that results in the rapid
expression of a group of proteins known as heat-shock proteins
(HSPs). HSPs function as molecular chaperones, playing
a variety of roles, including assisting in protein folding, targeting
damaged proteins for degradation, and other responses associ-
ated with the protection of cell from damage (Hartl, 1996; Jolly
and Morimoto, 2000). The induction of the heat-shock response
ismediated by heat-shock transcription factors (HSFs). Whereas
invertebrate animals such as nematodes typically have only one
HSF (Clos et al., 1990; Garigan et al., 2002), four distinct but
related HSF isoforms have been found in vertebrates (HSF14)
(Pirkkala et al., 2001). In response to stress, HSF acquires DNA
binding activity to the heat-shock elements (HSE) located in
the promoters of hsp genes, thereby mediating their transcrip-
tion. The activation of vertebrate HSF1 appears to be amultistep
process that includes oligomerization, posttranslational modifi-
cations, nuclear localization, and acquisition of DNA binding
activity (Sarge et al., 1993). However, not all of these steps are
essential for the activation of HSF in invertebrate species (Sorger
et al., 1987).
A decrease in the effectiveness of the heat-shock response
has been associated with aging and is partly responsible for
the age-related increase in mortality (Finkel and Holbrook,
2000). This age-related attenuation of the heat-shock response
is often related to a decrease in the capacity of cells to produce
HSPs (So´ti and Csermely, 2000). Several studies have directly
implicated heat-shock response genes, including HSF, in the
regulation of longevity. First, it has been reported that the
expression of genes encoding small heat-shock proteins
(sHSPs) is increased in Drosophila lines selected for increased
longevity (Kurapati et al., 2000), as well as in C. elegans daf-2
mutants (Murphy et al., 2003). Moreover, mild heat stress in
C. elegans results in a small but significant extension of life
span (Lithgow et al., 1995). Similarly, mild heat stress in
Drosophila causes a period of decreased mortality rate (Kha-
zaeli et al., 1997). It also has been found that overexpression
of hsf-1 leads to increased longevity, whereas inhibition of
HSF-1 activity by RNAi shortens the animal’s life span (Hsu
et al., 2003).
Recent studies have demonstrated that HSF-1 and its down-
stream targets may act in concert with the IIS pathway to regu-
late longevity in C. elegans. It has been reported that HSF-1,
similar to DAF-16, is required for daf-2 mutations to extend life
span (Hsu et al., 2003). It is also known that the expression of
a subset of heat-shock response genes is increased in daf-2
mutants under unstressed conditions and is at least partially
required for the life span phenotypes of daf-2 mutants (Hsu
et al., 2003). Together, these observations imply that the IIS
pathway might, at least in part, influence longevity by regulating
heat-shock response.
Here, we show that both the DNA binding and the transcrip-
tional activity of HSF-1 are directly regulated by IIS and that
this regulation likely occurs at an early step of HSF-1 activation.
We show that the proteins DDL-1 and DDL-2, previously impli-
cated in life span extension, modulate HSF-1 activity by forming
an inhibitory heterocomplex with HSF-1 and that formation of
this complex is regulated by IIS. Our findings suggest that these
HSF-1 regulators may link insulin/IGF-1 signaling and the cellular
response to heat stress.
RESULTS
The Activation of HSF-1 Is a Multistep Process
in C. elegans
Heat-shock transcription factor (HSF-1) is a key transcriptional
regulator of the cellular response to various proteotoxic
stresses, including heat, in C. elegans. The mammalian
HSF1 is constitutively present in cells and is activated when
cells encounter proteotoxic stresses. It has been well docu-
mented in other animal models that activation of HSF1
appears to be a multistep process, involving oligomerization,
inducible posttranslational modification, nuclear/subnuclear
localization, acquisition of DNA binding activity, and acquisi-
tion of transcriptional activity. All of these steps are shown
to be tightly controlled (reviewed in Morimoto, 1998; Voellmy,
2004). However, given the important role that C. elegans
HSF-1 might play in determining DAF-2 longevity, the activa-
tion and regulation of HSF-1 have not been thoroughly inves-
tigated. Thus, we first examined how C. elegans HSF-1
responds to heat stress.
To examine whether oligomerization of HSF-1 also occurs in
C. elegans, worm whole-cell extracts (WCE) were incubatedwith crosslinking reagent EGS before being analyzed by western
blotting with anti-human HSF1 antibody. We found that worm
HSF-1 forms both dimers and trimers upon heat shock (Fig-
ure S1A available online). We then asked whether HSF-1 is post-
translationally modified in response to heat shock. Results from
our western blotting analysis indicate that posttranslational
modifications (PTM) on HSF-1 proteins occur in a time-depen-
dent manner upon heat shock (Figure S1B). This change may
represent a shift from a nonmodified to a modified form of
HSF-1 or a shift between two different posttranslationally modi-
fied forms of HSF-1 in response to heat shock. Further analysis
with alkaline phosphatase (CIP) suggests that phosphorylation(s)
may be responsible for the majority of the PTM observed in
HSF-1 (Figure S1C). There are at least 12 phosphorylation sites,
both constitutive and inducible, that have been identified on
human HSF1 (Guettouche et al., 2005). The effects of phosphor-
ylation on HSF-1 activity, however, can be either positive or
negative.
One of the most important steps of HSF activation is for HSFs
to acquire DNA binding activity to the heat-shock element (HSE),
located in the upstream regulatory region of its target genes.
Thus, we examined whether heat shock leads to an induction
of HSF-1 DNA binding activity in worms, using an electropho-
retic mobility shift assay (EMSA) developed in our lab for
C. elegans HSF-1. As observed in other systems upon stimula-
tion, there is an increased level of HSF-1 that can bind to the
biotin-labeled HSE probes (Figure 1A). This binding can be out-
competed by unlabeled HSE containing oligonucleotides, but
not by randomly synthesized oligonucleotides, suggesting
a specific interaction between HSF-1 and HSE probes. More-
over, activated HSF-1 and HSE form a larger complex with
the anti-HSF1 polyclonal antibodies, but not with the anti-GFP
antibodies (Figure 1A).
Though the formation of active oligomers to acquire DNA
binding activity is conserved across species, there has been
some controversy regarding the subcellular localization of
HSF1 under unstressed conditions in different metazoan
systems. Some studies have suggested that HSF1 is predomi-
nantly cytoplasmic prior to heat shock and nuclear after stress
(Sarge et al., 1993; Sistonen et al., 1994), whereas others have
suggested that HSF1 is always nuclear (Mercier et al., 1999).
Using a transgenic line that expresses gfp-tagged hsf-1 under
the control of its own endogenous promoter, HSF-1-GFP was
observed in intestinal cells, body wall muscle cells, and hypo-
dermal cells, as well as many neurons in the head and tail. The
GFP signal can be reduced upon treatment with hsf-1 RNAi.
The HSF-1-GFP is evenly distributed between the nucleus and
cytoplasm before heat shock in intestinal cells (Figure 1B).
In response to 30 min of heat shock, an accumulation of
HSF-1-GFP was observed in the intestinal nuclei (Figure 1B).
Overexpression of the same hsf::gfp construct rescued the life
span-shortening effect of hsf-1(sy441) mutations (Hajdu-Cronin
et al., 2004) (Figure S1F) and produced a significant life span
extension on its own in a wild-type background (Figure S1G),
suggesting that the tagged HSF is fully functional. Together,
our findings suggest that the activation of HSF-1 in C. elegans
is also a multistep process and that these assays can be very
useful tools to assess HSF-1 activity.Cell 148, 322–334, January 20, 2012 ª2012 Elsevier Inc. 323
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Figure 1. Inactivation of daf-2 Positively Regulates HSF-1 Activity and Heat-Shock Response
(A) DNA binding activity ofC. elegans HSF-1 in response to 90 min of heat shock at 37C (HS), measured by electrophoretic mobility shift assay. Nuclear extracts
were incubatedwith biotin-labeled HSE probes (Biotin-HSE). The specificity of the DNA bindingwas determined by competition with 2003 unlabeledHSE probes
(HSE), randomly synthesized DNA (rDNA), anti-HSF-1 antibodies (Ab1), or anti-GFP antibodies (Ab2) before being applied to gel electrophoresis.
(B) Nuclear accumulation of HSF-1 in response to IIS inactivation. EQ73 animals (hsf-1::gfp) grown on vector control (VC) or different RNAi bacteria were
unstressed or heat shocked for 30 min (HS) before being classified into three groups according to the nuclear/cytosolic (n/c) ratio of GFP intensity in the intestinal
cells (right). ‘‘c,’’ ‘‘wn,’’ and ‘‘sn’’ are animals with n/c ratio < 1.2, 1.22.0, and > 2.0, respectively. The means of three independent experiments were pooled and
shown (left). *p < 0.0001 versus VC under same conditions (chi2 test). nR 300.
(C and D) The DNA binding activity of HSF-1 in daf-2(e1370)mutants in response to 90 min of heat shock (HS). The result of a representative experiment is shown
in (C). The mean ± SD of three independent experiments (mean ± SD), normalized to the control (N2 with unlabeled HSE), is presented in (D).
(E) N2 or daf-2(RNAi) animals were unstressed or heat shocked for 90 min (HS). Worm whole-cell extracts (WCE) of these animals were subjected to immu-
noblotting analysis using anti-HSF-1 (top) or anti-b-actin (bottom) antibodies. Detailed quantification is shown in Figure S1D.
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DAF-2 Insulin/IGF-1-like Signaling Inhibits
HSF-1 Activity
If insulin/IGF-1-like signaling (IIS) pathway influences longevity,
at least in part, by directly modulating HSF-1 activity and heat-
shock response, one would expect that a reduction in DAF-2
activity should promote the activation of HSF-1 and raise its
activity. To test this idea, we first investigated how reduction in
DAF-2 activity affects HSF-1 nuclear translocation and found
that there is a significantly higher level of HSF-1 localized in the
nucleus of daf-2(RNAi) animals compared to control before or
after heat shock (Figure 1B), indicating an elevated HSF-1 acti-
vation. This effect appears to be DAF-16 independent, as simul-
taneous knockdown of both daf-2 and daf-16 did not reverse the
phenotype (Figure 1B). Similarly, inactivation of another IIS
component AKT-1 by RNAi resulted in an increased HSF-1
nuclear localization, although the effect was smaller (Figure 1B).
We next examined how reduction in DAF-2 activity affects the
DNA binding activity of HSF-1. As predicted, we found that the
DNA binding activity of HSF-1 is increased 4-fold in unstressed
daf-2(RNAi) animals and more than 17-fold in heat-shocked
daf-2(RNAi) animals as compared to the unstressed wild-type
(N2) controls (Figures 1C and 1D), suggesting that the basal level
of HSF-1 activity might be higher in daf-2(RNAi) animals, which
may allow for a stronger response to heat stress. Presumably,
the increase in DNA binding activity of HSF-1 in response to
heat stress or daf-2 knockdown may result from a nuclear accu-
mulation of activated HSF-1 (i.e., the oligomerized and post-
translationally modified HSF-1). Indeed, results from western
blotting analysis indicate that there is an elevated level of post-
translationally modified HSF-1 in daf-2 mutants under both
unstressed and stressed condition (Figures 1E and S1D), sug-
gesting the presence of an increased amount of activated
HSF-1 in daf-2mutants. It is worth noting that the amount of total
HSF-1 was also increased in response to heat stress or daf-2
knockdown, whereas the level of unmodified HSF-1 remained
largely unaltered (Figure S1D). However, this increase in total
HSF-1 protein is unlikely to be regulated transcriptionally, as
the mRNA level of hsf-1 does not appear to be different in daf-
2(RNAi) animals compared to the control (Figure S3A). In fact,
mRNA level of hsf-1 is slightly reduced after heat-shock (Fig-
ure S3A), implying a potential negative feedback regulation at
the transcriptional level following the initial activation upon heat
shock. One possible explanation is that the modified and DNA-
bound HSF-1 proteins are less accessible for degradation.
Finally, to examine whether increased DNA binding activity of
HSF-1 results in an increase in its transcriptional activity, we
measured the mRNA level of four known targets of HSF-1 by
qRT-PCR in daf-2(RNAi) animals before and after heat stress.
The mRNA levels of these genes, including hsp-16.2, sip-1, and
two different hsp-70 s, are all increased in daf-2(RNAi) animals
under both stressed and unstressed conditions (Figures 1F, 1G,
S3C, and S3D). The upregulation of heat-shock protein expres-
sion observed in daf-2(RNAi) animals can be suppressed by(F and G) Relative abundance of (F) hsp-16.2 and (G) hsp-70 (F44E5.5)mRNA in w
The inset shows the mRNA level under unstressed conditions (without 90 min H
of each treatment is shown.
See also Figure S1.hsf-1 RNAi treatments (Figures 1F, 1G, S3C, and S3D), suggest-
ing that the observed changes in the expression are the result of
alteration in HSF-1 activity. Together, our findings suggest that
the HSF-1 activity is negatively controlled by the IIS pathway
and that multiple steps of HSF-1 activation are affected by inhib-
iting IIS under both stressed and unstressed conditions.
hsf-1 Is Required for ddl-1, ddl-2, and hsb-1
to Influence Longevity
Our findings, together with previous studies, strongly suggest
that HSF-1 activity is regulated by IIS. To further understand
this regulation and determine whether it is direct, we next at-
tempted to elucidate the mechanism underlying this regulation.
We focused on two daf-16-dependent longevity (ddl) genes
identified from a previous genome-wide RNAi screen for
longevity genes (Hansen et al., 2005).
ddl-1 and ddl-2 both encode evolutionarily conserved
proteins. DDL-1 is homologous to human coiled-coil domain-
containing protein 53 (CCDC53), whereas DDL-2 is the worm
homolog of human Wiskott-Aldrich syndrome protein and
SCAR homolog (WASH2) protein. WASH2 and CCDC53 are
both components of the WASH complex, which is involved in
the actin polymerization (Derivery et al., 2009). CCDC53 has
also been reported to potentially interact with the heat-shock
factor binding protein-1 (HSBP1) (Rual et al., 2005), a known
negative regulator of HSF-1 (Satyal et al., 1998). Results from
yeast two-hybrid experiments also suggested that worm
DDL-1 may interact with both HSB-1 and DDL-2 (Li et al.,
2004). The inhibitory activity of HSB-1 is achieved via protein-
protein interactions between HSB-1 and the oligomerization
motif of HSF-1 (Satyal et al., 1998). We therefore hypothesized
that DDL-1/2 (i.e., DDL-1 and DDL-2) and HSB-1 may regulate
the activity of HSF-1 via the formation of an inhibitory complex.
To test this hypothesis, we first asked whether hsf-1 is
required for ddl-1 and ddl-2 to influence longevity. The life spans
of hsf-1(sy441) mutants, which have been reported to exhibit
reduced heat-shock response and shortened life span (Hajdu-
Cronin et al., 2004), grown on ddl-1 or ddl-2 RNAi bacteria
were measured. We found that RNAi treatment of ddl-1 or
ddl-2 failed to produce any significant life span extension on
hsf-1(sy441) mutants (Figures 2A and 2B and Table 1), whereas
reducing expression of ddl-1 or ddl-2 by RNAi extends life span
by 12%–24% in our hands (Figures 2A and 2B and Tables 1 and
S1). This finding suggests that hsf-1 is required for the extended
life span observed in ddl-1 or ddl-2 RNAi-treated animals.
Consistent with the idea that DDL-1/2 may influence longevity
by altering HSF-1 activity, animals grown on ddl-1 or ddl-2
RNAi bacteria exhibit increased resistance to both heat and
oxidative stresses (Figures S2A and S2B). Although reducing
ddl-1/2 expression extends wild-type life span, overexpression
of ddl-1/2 is not sufficient to alter wild-type life span (Figures
S2C–S2E). Overexpression of ddl-1, however, does reverse the
life span-extending phenotypes of ddl-1(ok2916) mutantsild-types (N2) or daf-2(e1370)mutants fed with control or hsf-1 RNAi bacteria.
S). Data were combined from at least three experiments, and the mean ± SD
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Figure 2. A Common hsf-1-Dependent Mechanism Mediates the Longevity Effects of ddl-1, ddl-2, and hsb-1
(A) Life span analysis of wild-type (N2) animals or hsf-1(sy441) mutants grown on empty vector control or ddl-1 RNAi bacteria at 20C.
(B) Life span analysis of N2 animals or hsf-1(sy441) mutants grown on control or ddl-2 RNAi bacteria.
(C) Life span analysis of N2 animals or hsb-1(cg116) mutants grown on control or hsf-1 RNAi bacteria.
(D) Life span analysis of N2 animals grown on control, ddl-1 RNAi, ddl-2 RNAi, or 1:1 mixture of ddl-1 and ddl-2 RNAi bacteria at 20C.
(E) Life span analysis of N2, ddl-1(ok2916), hsb-1(cg116), or ddl-1(ok2916);hsb-1(cg116) mutants.
(F) Life span analysis of N2, ddl-2(ok3235), hsb-1(cg116), or ddl-2(ok3235);hsb-1(cg116) mutants.
Statistical details are summarized in Table 1 and Table S1. See also Figure S2.(Figure S2F). It is possible that the residual activity of HSF-1 is
sufficient to ensure survival under experimental conditions (at
20C, without heat stress).
Because HSB-1 is predicted to interact with both DDL-1 and
HSF-1, we have also examined whether the loss-of-function
mutation of hsb-1 increases life span. Indeed, the life span of326 Cell 148, 322–334, January 20, 2012 ª2012 Elsevier Inc.hsb-1(cg116) mutants, which harbors a null mutation of hsb-1,
is increased by up to 60% (Figure 2C and Table 1). Moreover,
hsf-1 is also required for the life span extension caused
by hsb-1 mutations, as hsb-1(cg116); hsf-1(RNAi) animals’
life spans are as short as hsf-1(RNAi) animals (Figure 2C and
Table 1).
Table 1. Effects of ddl-1, ddl-2, and hsb-1 Mutations on Life Span
Strain Mean Life Span ± SEM (Days) 75th Percentile (Days) P Value n
N2; control (i) 17.2 ± 0.3 21  67/90
N2; ddl-1(RNAi) (i) 19.1 ± 0.3 22 0.0034a 84/90
hsf-1(sy441); control 14.9 ± 0.1 16 <0.0001a 101/169
hsf-1(sy441); ddl-1(RNAi) 14.9 ± 0.3 17 <0.0001a, <0.0001b, 0.74c 96/170
N2; control (ii) 17.2 ± 0.2 20  63/82
N2; ddl-2(RNAi) (ii) 19.2 ± 0.2 22 0.0008a 68/86
hsf-1(sy441); control 13.6 ± 0.2 15 <0.0001a 86/156
hsf-1(sy441); ddl-2(RNAi) 13.2 ± 0.1 14 <0.0001a, <0.0001b, 0.26c 107/156
N2; control (iii) 19.1 ± 0.2 22  62/72
N2; hsf-1(RNAi) 11.2 ± 0.2 12 <0.0001a 46/72
hsb-1(cg116); control 30.0 ± 0.4 35 <0.0001a 74/84
hsb-1(cg116); hsf-1(RNAi) 11.1 ± 0.2 12 <0.0001a, 0.78b, <0.0001c 33/84
N2 (i) 18.9 ± 0.2 22  60/72
ddl-1(ok2916) 25.1 ± 0.3 27 <0.0001a 65/72
hsb-1(cg116) (i) 30.3 ± 0.5 35 <0.0001a 62/72
hsb-1(cg116); ddl-1(ok2916) 29.9 ± 0.3 35 <0.0001a, <0.0001d, 0.51e 57/72
N2 (ii) 17.1 ± 0.4 21  52/72
ddl-2(ok3235) 22.6 ± 0.3 26 <0.0001a 32/72
hsb-1(cg116) (ii) 26.8 ± 0.4 32 <0.0001a 32/72
hsb-1(cg116); ddl-2(ok3235) 28.6 ± 0.4 32 <0.0001a, <0.0026f, 0.32e 31/72
N2; control(RNAi) (iv) 17.2 ± 0.6 23  82/90
N2; ddl-1(RNAi) (iv) 21.3 ± 0.5 25 0.0006a 81/90
N2; ddl-2(RNAi) (iv) 21.4 ± 0.6 28 0.0001a 81/90
N2; ddl-1(RNAi); ddl-2(RNAi) 20.9 ± 0.3 25 0.0072a, 0.34g, 0.26h 86/90
Adult mean life span ± SEM in days. Life span experiments were carried out at 20C. The 75th percentile is the age at which the fraction of animals alive
reaches 0.25. ‘‘n’’ shows the number of observed deaths relative to total number of animals started. The difference between these numbers represents
the number of animals censored. Animals that exploded, bagged, or crawled off the plates were censored at the time of the event. The log rank (Mantel-
Cox) test was used for statistical analysis (p values). Data shown here represent one independent life span experiment. Please see Table S1 for addi-
tional repetitions of the experiments. See also Table S2.
a p values calculated by pairwise comparisons to N2 grown on vector control of the same experiment.
bCompared to N2 grown on the same RNAi bacteria.
cCompared to the same mutants grown on vector control.
dCompared to ddl-1(ok2916) mutants.
eCompared to hsb-1(cg116) mutants.
f Compared to ddl-2(ok3235) mutants.
gCompared to N2 grown on the ddl-1 RNAi bacteria of the same experiment.
hCompared to N2 grown on the ddl-2 RNAi bacteria of the same experiment.Taken together, our findings suggest that ddl-1, ddl-2, and
hsb-1 may share the same mechanism that involves hsf-1 to
influence longevity. Results from our genetic epistasis analysis
on ddl-1, ddl-2, and hsb-1 also support this model. First,
inhibition of both ddl-1 and ddl-2 by RNAi does not lead to
a larger life span extension compared to animals treated with
ddl-1 or ddl-2 RNAi alone, suggesting that ddl-1 and ddl-2
may have common effectors and act in the same genetic
pathway (Figure 2D and Table 1). Second, we found that inhibi-
tion of ddl-1 does not further increase the life span of hsb-
1(cg116) mutants, whereas it typically increases N2 life span
by up to 33% (Figure 2E and Table 1). We also tested the life
span of hsb-1(cg116) mutants grown on ddl-1 RNAi and found
no additive effect (data not shown). Similarly, the life span of
hsb-1(cg116); ddl-2(ok3235) double mutants is not statisticallydifferent from hsb-1(cg116) single mutants (Figure 2F and
Table 1). Together, these findings imply that a common mech-
anism might mediate the life span phenotypes of ddl-1, ddl-2,
and hsb-1 mutations.
DDL-1/2 Negatively Regulate HSF-1 Activity
HSB-1 is known to control cellular response to heat stress by
negatively regulating HSF-1 activity. Therefore, if ddl-1/2 and
hsb-1 were to influence longevity through a common mecha-
nism, the most likely common effectors would be HSF-1. To
test whether DDL-1/2 exert their functions by negatively regu-
lating HSF-1 activity, we measured the DNA binding activity
of HSF-1 in ddl-1(RNAi) and ddl-2(RNAi) animals. Inhibition of
ddl-1 appears to increase DNA binding activity of HSF-1 both
before and after heat shock (Figures 3A and 3B). There isCell 148, 322–334, January 20, 2012 ª2012 Elsevier Inc. 327
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Figure 3. DDL-1 and DDL-2 Negatively Regulate
HSF-1 Activity
(A and B) Lowering ddl-1 or ddl-2 expression increases
HSF-1 DNA binding activity. The DNA binding activity of
HSF-1 in N2, ddl-1(RNAi), or ddl-2(RNAi) animals was
measured by EMSA before or after 90 min of heat shock
(HS). A representative experiment is shown in (A). Quan-
tification of three independent experiments (mean ± SD) is
presented in (B).
(C and D) Relative abundance of (C) hsp-16.2 and (D) hsp-
70 (F44E5.5) mRNA in N2, hsf-1(RNAi), ddl-1(RNAi), or
ddl-2(RNAI) animals with or without heat shock (90 min).
The inset shows the mRNA level under unstressed
conditions. The means ± SD of three independent exper-
iments were pooled and shown here.
(E) Nuclear accumulation of HSF-1 in response to DDL-1/2
inactivation. EQ73 animals (hsf-1::gfp) grown on control,
ddl-1, or ddl-2 RNAi bacteria were unstressed or heat
shocked for 30 min (HS). The results of three experiments
were pooled and shown here. Data are mean, nR 300 per
RNAi treatment. *p < 0.0001; #p = 0.097 (chi2 test).
(F) Worm whole-cell extracts (WCE) prepared from N2,
ddl-1(RNAi), or ddl-2(RNAi) animals with or without 90 min
of HS were subjected to immunoblotting analysis using
anti-HSF-1 (top) or anti-b-actin (bottom) antibodies.
Detailed quantification is shown in Figure S1D. See also
Figure S3.also a significant increase in DNA binding activity of HSF-1 in
ddl-2(RNAi) animals under stressed condition, whereas inhibit-
ing ddl-2 under unstressed conditions produced no significant
effect (Figures 3A and 3B). We then asked whether increased
HSF-1 DNA binding activity results in an increase in its tran-
scriptional activity. A similar pattern was observed when we
examined the effect of inhibiting ddl-1 or -2 on HSF-1 transcrip-
tional activity by qRT-PCR. Inhibition of ddl-1 or -2 led to
increases in mRNA transcription of all four hsp genes after
heat shock (Figures 3C, 3D, S3E, and S3F). However, under
unstressed conditions, inhibition of ddl-1 or -2 did not signifi-
cantly elevate the mRNA level of hsf-1 targets, except for the
hsp-16.2 and sip-1 in ddl-1(RNAi) animals (Figures 3C, 3D,
S3E, and S3F).
Presumably, the changes in HSF-1 activity observed in ddl
mutants might be due to changes in the amount of nuclear
localized and activated HSF-1. Indeed, we found that there
is a significantly higher level of nuclear localized HSF-1 in
ddl-1(RNAi) animals under both stressed and unstressed
condition and in ddl-2(RNAi) animals under stressed condition328 Cell 148, 322–334, January 20, 2012 ª2012 Elsevier Inc.(Figure 3E). We also found an increased
level of posttranslationally modified HSF-1 in
ddl-1(RNAi) animals under stressed and
unstressed condition (Figures 3F and S1D).
Curiously, the level of HSF-1 PTM is slightly
reduced in ddl-2(RNAi) animals (Figure 3F
and S1D), suggesting that DDL-1 and DDL-2
may regulate HSF-1 activity via both overlap-
ping and distinct mechanisms. Together, our
findings strongly support the hypothesis
that HSB-1, DDL-1, and DDL-2 might func-tion as negative regulators of HSF-1 to influence longevity in
worms.
DDL-1/2 Form a Heterocomplex with HSB-1 and HSF-1
Having established that DDL-1/2 inhibits HSF-1 activity and
thereby suppresses HSF-1-dependent gene expression, we
next asked how DDL-1/2 controls HSF-1 activity. It has
been shown that the activity of mammalian HSF1 can be
negatively regulated by the interaction between HSF1 and
its binding proteins (Zuo et al., 1995). Therefore, it is possible
that DDL-1/2 may regulate HSF-1 activity by forming a heter-
ocomplex with HSB-1 and HSF-1 to keep HSF-1 in its inactive
form.
To test this hypothesis, we first examined the interactions
between DDL-1 and DDL-2 in a cell culture system. Plasmids
containing HA-tagged DDL-1 and/or FLAG-tagged DDL-2
were transfected into the 293T human renal epithelial cells.
Coimmunoprecipitation (Co-IP) analyses were then performed
to examine whether DDL-1 interacts with DDL-2. When cell
extracts were immunoprecipitated with antibodies against
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Figure 4. DDL-1 Forms a Protein Complex with
HSF-1, HSB-1, and DDL-2 in a Cell Culture Model
and in C. elegans
(A) DDL-1 interacts with DDL-2 in 293T cells. Here and in
(B) and (C), 293T cells were transfected with indicated
combinations of pCMV-HA-DDL-1, pFLAG-CMV2-DDL-2,
pFLAG-CMV2-DDL-1, pCMV-Myc-HSB-1, or pCMV-Myc-
HSF-1 plasmids. Whole-cell extracts were then immuno-
precipitated (IP) and subsequently western blotted (WB)
using indicated antibodies.
(B) DDL-1 interacts with HSB-1 in 293T cells.
(C) DDL-1 may form a protein complex with HSF-1 in 293T
cells.
(D) DDL-1 may form a protein complex with HSF-1 in
C. elegans. Worm whole-cell extracts (WCE) were
prepared from N2, EQ136 (HA-ddl-1 o.e.), or EQ193
(HA-ddl-1 o.e.; hsb-1(cg116)) animals. Samples were
immunoprecipitated and subsequently western blotted
using indicated antibodies.
(E) DDL-1 interacts with DDL-2 in C. elegans. WCE were
prepared from N2 or EQ155 animals expressing both
HA-DDL-1 and FLAG-DDL-2 proteins. Samples were
immunoprecipitated and western blotted using indicated
antibodies.HA-tag and blotted with antibodies against FLAG-tag, we
were able to detect the FLAG-DDL-2 proteins (Figure 4A).
Similarly, HA-DDL-1 proteins can be pulled down together
with DDL-2 using the anti-FLAG antibody (Figure 4A). We
then asked whether DDL-1 interacts with HSB-1. Our Co-IP
results indicated that HSB-1 can be pulled down by an anti-
body against tagged DDL-1 and vice versa (Figure 4B). These
findings suggest that DDL-1 may physically interact with
HSB-1 and DDL-2 or at least be present in a protein complex
containing all three of them. Thus, if DDL-1 functions by
forming an inhibitory complex of HSF-1, one may predict
the presence of HSF-1 in this heterocomplex consisting of
at least HSB-1, DDL-1, and DDL-2. Indeed, immunopre-
cipitation with antibodies against either tagged HSF-1 or
DDL-1 successfully pulled down each other in 293T cells
(Figure 4C).
To examine whether a similar protein complex is formed in
C. elegans, we constructed a transgenic line overexpressing
HA-ddl-1. Co-IP experiments were then carried out with protein
samples isolated from these worms. Consistent with our obser-Cell 148, 32vations in cell culturemodel, wewere able to pull
down endogenous worm HSF-1 together with
DDL-1 using antibodies against HA-tagged
DDL-1 (Figure 4D). Similarly, interaction
between DDL-1 and DDL-2 in worms is
confirmed by Co-IP using a transgenic line
overexpressing both HA-ddl-1 and Flag-ddl-2
(Figure 4E). Co-IP experiments with transgenic
animals in hsb-1() background indicate
that the formation of this heterocomplex
largely depends on the presence of HSB-1 (Fig-
ure 4D). Together, our findings suggest thatthere is an evolutionarily conserved interaction between DDL-1
and its binding partners.
The Formation of DDL-1-Containing HSF-1 Inhibitory
Complex Is Promoted by IIS
As we have demonstrated, the ability of HSF-1 to turn on tran-
scription is negatively regulated by the IIS (Figure 1). However,
one major question that remains to be addressed is how
DAF-2 controls the HSF-1 activity, which consequentially influ-
ences both longevity and cellular responses to heat. As a first
step in exploring a molecular connection between the IIS
pathway and HSF-1 activity, we investigated the impact of
inhibiting IIS on the formation of DDL-1-containing HSF-1
inhibitory complex (DHIC). N2 and EQ136 animals (i.e., the HA-
ddl-1 o.e. line) grown on control, daf-2, or akt-1 RNAi bacteria
were harvested and subjected to Co-IP analysis. The proteins
pulled down with anti-HA antibodies were then subjected to
western blotting analysis using anti-HSF or anti-HA antibodies.
We found that the amount of HSF-1 pulled down with DDL-1
is significantly reduced in EQ136 animals fed with daf-2 or2–334, January 20, 2012 ª2012 Elsevier Inc. 329
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Figure 5. Both the Formation of DHIC and the Threonine Phos-
phorylation of DDL-1 Are Regulated by IIS
(A) The formation of DHIC is disrupted by IIS inactivation. Worm whole-cell
extracts (WCE) prepared from N2 or EQ136 (HA-ddl-1 o.e.) adult animals
grown on control, daf-2, akt-1, or a 1:1 mixture of daf-2 and daf-16 RNAi
bacteria were subjected to immunoprecipitation (IP) and western blotting
analysis (WB) with indicated antibodies. The total HSF-1 input of each IP
experiment was measured by blotting each WCE sample with anti-HSF1
antibodies.
(B) Whole-cell extracts prepared from 293T cells overexpressing HA-DDL-1
were treated with buffer or 1 U/mg protein CIP (alkaline phosphatase) for 1 hr.
Samples were then subjected to western blotting analysis (WB) with anti-HA
antibodies.
(C) Whole-cell extracts prepared from 293T cells overexpressing HA-tagged
wild-type or mutated (T182A) DDL-1 were subjected to western blotting
analysis (WB) using anti-HA or anti-phosphothreonine antibodies.
(D) 293T cells were transfected with indicated combinations of pCMV-driven
HA-DDL-1(WT), HA-DDL-1(T182A), or Myc-HSF-1 plasmids. Whole-cell
extracts prepared from these cells were immunoprecipitated (IP) and subse-
quently western blotted (WB) using indicated antibodies.
(E) The level of threonine-phosphorylated DDL-1 is elevated in daf-2 mutants.
WCE prepared from N2 or EQ136 worms grown on control or daf-2 RNAi
bacteria were immunoprecipitated and western blotted using indicated anti-
bodies.
Shown here (A, D, and E) are the immunoblots of a representative experiment.
Quantification of at least three experiments is shown in Figure S4.akt-1RNAi bacteria (Figures 5A and S4A). The decreases in DDL-
1-coprecipitated HSF-1 are likely due to an alteration on the
formation of DHIC by IIS, as the mRNA levels of hsf-1, ddl-1,
ddl-2, or hsb-1 are not altered (Figures S3A and S4E) and the
total protein level of HSF-1 is actually increased (Figures 1E
and S1D) in daf-2(RNAi) animals. This effect of IIS on the forma-
tion of DHIC appears to be DAF-16 independent, as daf-16
knockdown does not rescue the phenotype observed in daf-2
mutants (Figure S4A). Intriguingly, we also found that heat stress
does not affect the formation of DHIC (Figure S4A), suggesting
the presence of a separate DHIC-independent regulation on
HSF-1 activity upon heat stress.
Phosphorylation of DDL-1 Disrupts the Formation
of DHIC
Similar to HSF-1, results from our western blotting analysis have
suggested that DDL-1 is also posttranslationally modified (Fig-
ure 5B). CIP treatment results indicate that phosphorylation
accounts for a majority of PTM on DDL-1 (Figure 5B). Western
blotting analysis with anti-pThr antibodies suggests that at least
one of the threonine residues on DDL-1 is phosphorylated (Fig-
ure 5C). There are five putative phospho-threonine (pThr) sites
on DDL-1, as predicted by PredPhospho (Kim et al., 2004).
Two of these, Thr-171 and Thr-182, are located in close prox-
imity to an evolutionarily conserved region that also contains
a predicted pThr site (Thr-181) on human CCDC53. Thus, we
constructed expression plasmids that encode DDL-1with a thre-
onine-to-alanine mutation at Thr-171 or Thr-182. Our results
indicate that the Thr-182-to-Ala (T182A) mutation completely
eliminates the threonine phosphorylation on DDL-1 (Figure 5C).
Conversely, T171A mutation produced no detectable effect on
the phosphorylation of DDL-1 (data not shown). This finding
suggests that Thr-182might be the only Thr residue that is phos-
phorylated on DDL-1. However, additional phosphorylations on
non-Thr residues (e.g., Ser or Tyr) are likely to be present, as
the PTM on DDL-1 is decreased but not abolished by T182A
mutation (Figure 5C).
Next, we asked whether the formation of DHIC is affected by
the phosphorylation status of DDL-1. To address this, we carried
out Co-IP experiments with either native or T182A DDL-1 in 293T
cells. We found that the amount of DDL-1 that coprecipitated
with HSF-1 is significantly higher when the Thr-182 residue of
DDL-1 is mutated and not phosphorylated (Figures 5D and
S4C). Together, our findings suggest that the phosphorylation
at Thr-182 of DDL-1 may promote DHIC dissociation and conse-
quently the oligomerization and activation of HSF-1, although the
kinase(s) that phosphorylates DDL-1 remains unknown.
Threonine Phosphorylation of DDL-1 Is Regulated by IIS
How might IIS control DHIC formation? Having established that
the threonine phosphorylation of DDL-1 negatively impacts
DHIC formation and thereby promotes HSF-1 activation, one
possibility is that IIS may control the HSF-1 activity by modu-
lating the phosphorylation status of DDL-1. To test this idea,
we examined the level of threonine-phosphorylated DDL-1 in
daf-2(RNAi) animals. Samples harvested from EQ136 animals
(HA-ddl-1) fed with vector control or daf-2 RNAi bacteria were
IP’d with anti-pThr antibodies and blotted with antibodies330 Cell 148, 322–334, January 20, 2012 ª2012 Elsevier Inc.against HA tag. Consistent with the model, we found that inacti-
vating DAF-2 elevates the ratio of threonine-phosphorylated
DDL-1 to total DDL-1 by more than 5-fold (Figures 5E and S4D).
p 
p 
  
DAF-2  
(insulin/IGF-1-like receptor) 
Insulin-like peptides 
DDL-2 
HSE 
Gene  
Transcriptions 
Nucleus 
Cytosol 
Plasma membrane 
p 
p 
p p 
The insulin/IGF-1-like  
signaling cascade 
Oligomerization 
 raelcuN
Translocation 
Post-translational 
Modification 
DNA binding 
HSF-1 
HSB-1 
HSF-1 
HSB-1 
DDL-2 
DDL-1 
Heat-shock 
DHIC DDL-1 
p 
DDL-1 Phosphorylation 
& DHIC Dissociation 
p 
HSP70/90?
Figure 6. Model of HSF-1 Activation Regulated by IIS in C. elegans
Upon heat stress stimulation, HSF-1 undergoes oligomerization, post-
translational modification, and nuclear translocation in an undefined order
before acquiring DNA binding and transcriptional activity. The formation of
a DDL-1-containing HSF-1 inhibitory complex (DHIC), consisting of HSF-1,
HSB-1, DDL-1, and DDL-2, reduces the pool of HSF-1 susceptible to heat
stress stimulation. Increased insulin/IGF-1-like signaling (IIS) promotes the
formation of DHIC, whereas reducing DAF-2 activity promotes DDL-1 phos-
phorylation and disrupts DHIC formation and consequently increases HSF-1
activity under both stressed and unstressed conditions. See also Figures S5
and S6.DISCUSSION
Although the roles of HSF-1 and heat-shock-responsive genes in
the regulation of stress responses and longevity have been
previously described in C. elegans, how the HSF-1 activity is
modulated at the molecular level in response to different envi-
ronmental or even hormonal cues remains unknown. The work
presented here provides an array of evidence for a possible
mechanism underlying the regulation of HSF-1 activation by
the IIS pathway, one of the major regulatory pathways for
longevity. In this model, DDL-1/2 and HSB-1 negatively regulate
HSF-1 activity by forming a protein complex with HSF-1 that
consequently reduces the amount of HSF-1 susceptible to
heat stress-induced activation. IIS controls HSF-1 activity, at
least in part, by regulating the formation of this DDL-1-containing
HSF-1 inhibitory complex (DHIC), possibly via modulating the
threonine phosphorylation status of DDL-1 (Figure 6).
DDL-1 and DDL-2 as Negative Regulators of HSF-1
In mammalian cells, HSF1 activity may be negatively regulated
by the intramolecular interaction between HSF1 and its binding
proteins (Zuo et al., 1995). For example, mammalian HSF-1
forms inhibitory complexes with proteins such as Hsp90,
Hsp70, and p23 (Voellmy, 2004). Similarly, we found that
DDL-1/2 may also regulate HSF-1 activity by forming an inhibi-
tory complex containing at least HSF-1, HSB-1, and DDL-1/2
(i.e., DHIC). In both cell culture and C. elegans models, DDL-1
appears to interact with, or at least coexist in the same complex
with, HSF-1, DDL-2, and HSB-1 (Figures 4A–4E), whereas
HSB-1 is required for the formation of this protein complex
(Figure 4D).
Although our Co-IP results strongly suggest the presence of
the DHIC in vivo, we cannot completely exclude the possibility
that protein-protein interactions occurred after cell lysis.
However, several lines of evidence suggest that this is unlikely
to be the case. First, the protein-protein interaction observed
between DDL-1 and HSF-1/HSB-1 can be disrupted by genetic
manipulations, such as RNAi knockdown of daf-2, without
affecting the overall protein levels of DDL-1 (Figure 5A). This
finding implies that the interaction observed is specific and likely
occurs in vivo. Furthermore, human orthologs of DDL-1, DDL-2,
and HSB-1 have been reported to either interact with each other
or coexist in the same protein complex (Derivery et al., 2009;
Rual et al., 2005), suggesting that the formation of DHIC may
be conserved across species. Finally, HSF-1 is expressed in
almost all cell types, as observed in our hsf-1::gfp transgenic
lines, whereas HSB-1 is found to be expressed in a variety of
tissues such as pharynx, intestine, muscles, and tail neurons
(Hunt-Newbury et al., 2007). Similarly, strong DDL-1 expression
is observed in the cytoplasm of many of the same tissues (e.g.,
pharynx, intestine, body wall muscle, and a subset of head and
tail neurons; Figure S5). The overlap in expression pattern among
HSF-1, HSB-1, and DDL-1 supports the idea that they do coloc-
alize and interact with each other in vivo.
DDL-2, on the contrary, is mainly expressed in a subset of
neurons, larval body wall muscles, and a small number of adult
intestinal cells (Figure S6). However, it is not clear whether the
expression of DDL-2 in those neurons is indeed critical in regu-lating HSF-1 activity and longevity. Further studies are required
to address these questions.
Direct Regulation of HSF-1 Activity by IIS
HSF-1 has been postulated to play a key role in mediating many
of the beneficial health effects observed in long-lived IIS pathway
mutants (Cohen et al., 2006; Hsu et al., 2003; Morley and
Morimoto, 2004). It is also known that the upregulation of certain
HSF-1 targets is at least partially responsible for the life span
extension observed in IIS pathway mutants (Hsu et al., 2003).
However, it was not clear whether the activity of HSF-1 is under
the direct control of IIS. In a recent study, McColl et al. reported
that, whereas the overall mRNA levels of several HSPs are
significantly increased in IIS mutants, the DNA binding activity
of HSF-1 and the stability of HSP mRNA may not be altered by
IIS (McColl et al., 2010). However, the EMSA experiments wereCell 148, 322–334, January 20, 2012 ª2012 Elsevier Inc. 331
done using a DNA probe containing four predicted HSF-1
binding motifs (HSE) without surrounding sequences found in
endogenous hsp promoters. Using a different probe containing
endogenous HSEs found in hsp-16.2 promoter, our results
indicate that the DNA binding activity of HSF-1 is upregulated
by IIS in a daf-16-independent manner (Figure 1). Moreover,
multiple steps of HSF-1 activation, including PTM and nuclear
translocation, are also modulated by IIS (Figure 1).
The most compelling evidence for a direct regulation of HSF-1
activity by IIS comes from our study on the effects of IIS inhibition
on DHIC formation. First, we found that the formation of DHIC is
largely diminished when IIS is reduced (Figure 5A), suggesting
that IIS may regulate HSF-1 activity by controlling the formation
of DHIC. Furthermore, we found that the formation of DHIC is
affected by the phosphorylation status of DDL-1, particularly at
the Thr-182 residue, and that the level of threonine-phosphory-
lated DDL-1 is dramatically increased in daf-2() mutants (Fig-
ure 5D and 5E). Although DAF-16 is known to act downstream
of IIS to control the expression of several stress response genes,
it appears that DAF-16 is not involved in this regulation
(Figure S4A).
While the phosphorylation status of DDL-1 may play a key role
in the regulation of DHIC formation and HSF-1 activity, the
protein kinase(s) that phosphorylates DDL-1 remains unknown.
The DDL-1 Thr-182 residue is predicted to be phosphorylated
by a glycogen synthase kinase 3 (GSK-3)-like kinase by Pre-
dPhospho. However, RNAi knockdown of both GSK-3 isoforms
in worms does not significantly affect the phosphorylation status
of T182 (Figure S4D). Similarly, inhibition of AKT-1, a kinase
downstream of DAF-2, does not attenuate pT182 level. In fact,
the level of pT182 is increased, as observed in daf-2 mutants
(Figure S4D), suggesting that DDL-1 is not a substrate of
AKT-1. Further investigations are required to identify the
kinase(s) responsible for the phosphorylation of DDL-1.
Multiple Layers of Regulations of HSF-1 Activity
It is well known that an acute increase of HSF-1 activity can be
induced by heat or other environmental stresses. Our study
has shown that HSF-1 activity is also subjected to hormonal
regulation, which occurs in a more chronic fashion. In addition
to their temporal differences, the IIS appears to regulate HSF-1
activity via a molecular mechanism independent of the stress-
induced activation of HSF-1, as heat stress does not affect the
formation of DHIC (Figure S4A). This also implies that the IIS
pathway and DHIC may be important for controlling the amount
of HSF-1 that is susceptible to heat stress stimulation but is not
required for the heat stress-inducedHSF-1 activation. Therefore,
IIS plays more of a modulatory role with respect to HSF-1
activity. This is different from the mechanism by which IIS regu-
lates other transcription factors, such as DAF-16 and SKN-1, as
reduced IIS leads to strong activations and dramatic increases in
nuclear occupancy of these proteins.
Insulin and IGF-1 signaling are known to be involved in many
key physiological processes, including metabolism, develop-
ment, growth, reproduction, and aging. Recently, it has also
been linked to the cellular stress responses. Similarly, though
HSFs are best recognized as the master regulators of the heat-
shock response and protein homeostasis, they also contribute332 Cell 148, 322–334, January 20, 2012 ª2012 Elsevier Inc.to other physiological processes such as development and
aging. Our findings presented here have provided a potential
mechanism at the molecular level that links these two pathways
together. Because most of the components of IIS and HSF-1
pathways found in worms are evolutionarily conserved, future
studies aimed at better understanding the crosstalk between
worm IIS and HSF pathways will shed light on the mechanisms
by which the aging process is controlled across species.
EXPERIMENTAL PROCEDURES
C. elegans Strains and Methods
Please see the Supplemental Information for the list of strains used in this
study. Animals were cultured on NGM plates seeded with E. coli at 15C, using
the standard method. All animals were cultured for at least two generations
without starvation before the experiments were initiated.
Life Span Analysis
Life span analysis was conducted at 20C as previously described unless
otherwise stated (Kenyon et al., 1993). RNAi treatments were carried out by
adding synchronized eggs to plates seeded with the RNAi bacteria. Worms
were moved to plates with fresh RNAi bacteria every 2 days until reproduction
ceased. Worms were then moved to new plates every 5-7 days for the rest of
the life span analysis. Viability of the worms was scored every 2–3 days.
Preparation of Worm Nuclear Extracts
Frozen wormpellets were homogenized in a Kontes Pellet Pestle tissue grinder
in the presence of an equal volume of 2 3 NPB buffer. Cells were pelleted
(4,000 3 g, 5 min, 4C) and then homogenized 20 strokes with pestle A of
the Dounce homogenizer. The suspension was then washed three times in
NPB buffer containing 0.25% NP-40 and 0.1% Triton X-100. The nuclei were
pelleted again and extracted with 43 volume of HEG buffer at 4C for
45 min. The nuclear fraction was collected by centrifugation at 14,000 3 g,
4C for 15 min. Protein concentrations were determined by Bradford assay.
Please see the Supplemental Information for buffer recipes.
Electrophoretic Mobility Shift Assay
1 mg of worm nuclear extracts (NE) was incubatedwith 1 mg/ml Poly (dI,dC) and
1 nM biotin-labeled oligonucleotide containing the HSE sequence for 15min at
room temperature in binding buffer (buffer recipes in Supplemental Informa-
tion). The biotin-labeled oligonucleotides were synthesized based on the
sequence covering the HSE in the promoter region of hsp-16.1 (detailed
sequence in Supplemental Information) Following native 3.5% polyacrylamide
gel electrophoresis, HSF-1-HSE DNA complexes were visualized by LightShift
Chemiluminscent EMSA kit (Pierce).
HSF-1 Nuclear Localization Assay
Day 2 adult animals carrying an integrated hsf-1::gfp array (EQ73) grown on
a vector control (VC) or different RNAi bacteria were either unstressed or
heat shocked on 37C heat block for 30 min. Fluorescence images of the
animals were then taken and scored blindly for the nuclear accumulation of
HSF-1::GFP protein in the intestinal cells (white arrows). At least 100 animals
were scored per RNAi treatment per experiment. Worms were classified into
separate groups according to the nuclear/cytosolic (n/c) ratio of GFP intensity
in the intestinal cells.
Coimmunoprecipitation in 293T Cells
Twenty-four hours after 293T cells were transfected with various combinations
of different plasmids containing HA-ddl-1, FLAG-ddl-1, FLAG-ddl-2, myc-
hsb-1, or myc-hsf-1 cDNA cells were washed with PBS and resuspended in
L-RIPA buffer (buffer recipes in Supplemental Information). The cell suspen-
sions were then placed on ice for 10 min before being subjected to centrifuga-
tion at 14,0003 g for 10min at 4C. The supernatants were then collected. The
protein levels of whole-cell extract (WCE) were quantified by Bradford assay.
For each sample, 1,000 mg of total protein was used for the IP experiments.
Anti-HA (Convance, #MMS101P), anti-FLAG (Sigma, #F3165), or anti-Myc
(Cell Signaling, #2276) antibodies were added to WCE at 1:150, 1:300, and
1:500 dilutions, respectively. Five mg of anti-mouse rabbit polyclonal antibody
was then added as a bridge antibody. Reactions were incubated at 4C with
gentle shaking overnight. 30 ml of 50% Protein A agarose beads (Sigma
#P7786; preblocked by 10% BSA) were added into the solutions 4–5 hr after
the initiation of the incubation. The beads were washed three times with
L-RIPA buffer supplemented with 50 mg/ml ABESF and 1 mM sodium orthova-
nadate before being subjected to western blotting analysis.
Coimmunoprecipitation in Worms
About 15,000 synchronized day 1 adult worms grown on either control or RNAi
bacteria at 20C were harvested by washing three times with cold M9 buffer
and onemore time with HB-high salt buffer (buffer recipes are found in Supple-
mental Information). Worm pellets were then resuspended in 33 volume of
HB-high salt buffer supplemented with Protease Inhibitor Cocktail Complete
Mini (Roche), 2.5 mM sodium pyrophosphate, 20 mM b-glycerolphosphate,
and 1 mM sodium orthovanadate. The pellets were immediately frozen and
stored in liquid nitrogen for future use. Frozen suspensions were thawed,
homogenized with a Dounce homogenizer (30 strokes with a pestle B), and
centrifuged at 14,000 3 g at 4C for 20 min. Supernatants (i.e., the worm
WCE) were collected and total protein concentrations were quantified by
Bradford assay. If necessary, crosslinking was done by incubating worm
protein extracts with 1 mM EGS (ethylene glycol bis[succinimidyl succinate])
at 25C for 30 min. The crosslinking reactions were stopped by adding and
incubating with 20 mM Tris-HCl (pH 7.4) for an additional 30 min. For immuno-
precipitation, 30 ml of anti-HA agarose beads (Sigma #A2095) were added to
1,500 mg of protein extract and incubated with gentle shaking at 4C over-
night. The beads were then washed three times with HB-high salt buffer sup-
plemented with 50 mg/ml ABESF and 1 mM sodium orthovanadate before
being subjected to western blotting analysis.
Western Blotting Analysis
The samples were subjected to SDS-PAGE and transferred to a PVDF
membrane (Millipore). The transblotted membrane was washed three times
with TBS containing 0.05% Tween 20 (TBST). After blocking with TBST con-
taining 5% nonfat milk for 60 min, the membrane was incubated with the
primary antibody indicated (e.g., anti-HSF1, Calbiochem, #385580) at 4C
for 12 hr and washed three times with TBST. The membrane was then probed
with HRP-conjugated secondary antibody for 1 hr at room temperature and
washed with TBST three times. Finally, the immunoblots were detected using
a chemiluminescent substrate (Pierce) and visualized by autoradiography.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and two tables and can be found with this article online at doi:10.
1016/j.cell.2011.12.019.
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